Multimorbidity, depression with anxiety symptoms, and decrements in health in 47 low- and middle-income countries

• Published in: Journal of affective disorders Vol. 317; pp. 176 - 184
• Main Authors: Felez-Nobrega, M., Haro, J.M., Koyanagi, A.
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 15.11.2022
• Subjects: Anxiety; Depression; Low- and middle-income countries; Multimorbidity; Depression; Anxiety; Low- and middle-income countries; Multimorbidity
• ISSN: 0165-0327; 1573-2517
• DOI: 10.1016/j.jad.2022.08.110

Comorbid depression and anxiety is associated with worse health outcomes compared to depression or anxiety occurring in isolation, but there is little data on its association with multimorbidity. Thus, we investigated this association across 47 low- and middle-income countries, and further explored whether having anxiety symptoms in addition to depression is associated with significant declines in health outcomes among those with multimorbidity. Cross-sectional, predominantly nationally representative, community-based data were analyzed from the World Health Survey. DSM-IV depression was assessed with the Composite International Diagnostic Interview. Anxiety symptoms referred to severe/extreme problems with worry or anxiety. Ten chronic conditions and health status across five domains (cognition, interpersonal activities, sleep/energy, self-care, pain/discomfort) were assessed. Multivariable regression analyses conducted. Data included 237,952 adults aged ≥18 years [mean age (SD) 38.4 (16.0); 50.8 % females]. Compared to no chronic conditions, 2 (OR = 6.86; 95%CI = 5.59–8.42), 3 (OR = 12.33; 95%CI = 9.72–15.63), and ≥4 (OR = 26.55; 95%CI = 20.21–35.17) chronic conditions were associated with significantly higher odds for comorbid depression/anxiety symptoms (vs. no depression or anxiety symptoms) in the multinomial logistic regression model. Among those with depression and multimorbidity, anxiety symptoms were associated with significantly worse health status across all domains. Cross-sectional design, depression and anxiety symptoms were not based on a clinical assessment. Comorbid depression/anxiety is common in people with multimorbidity, and anxiety symptoms in people with depression and multimorbidity signify worse health status. Future studies should assess the utility of screening for and treating comorbid depression/anxiety in patients with multimorbidity in terms of clinical outcomes. •Data on 237,952 adults aged ≥18 years from 47 low- and middle-income countries were analyzed.•Multimorbidity was associated with higher odds for comorbid depression/anxiety symptoms.•Among those with multimorbidity and depression, having anxiety symptoms was associated with significantly worse health outcomes.